Oncopeptalks on congresses and CD selection

For a biotech company, attending global industry congresses to interact with key stakeholders, gain insights and competitive intelligence is a critical part. These face to face interactions provide a platform for the medical community, patient organizations and the industry to meet and exchange knowledge and experiences.

In this edition of Oncopeptalks, Denise Luxenburg Stuifbergen, Associate Project Director, joins Sofia Heigis, CEO, to tell us about the journey Oncopeptides has taken and how its congress presence and perception has changed over the last two years.

Also, Sofia shares her perspective on the recent news that Oncopeptides has selected its’ first drug candidate from its unique SPiKE platform.

Watch the video below. Also available in Swedish, with similar content here.